Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
This channel is growing rapidly in tandem with subscription models and emerging mobile health platforms
The 2-year STEP 5 trial found strong tolerability
Phase 1: First in Human NCT04143802 | Published: The Lancet, 2022 (Coskun et al.) The first-in-human study of retatrutide was a single- and multiple-ascending-dose trial in patients with type 2 diabetes
5 Signs You Need to Visit Your Primary Care Physician Experiencing fatigue, unexplained weight changes, or persistent pain
US$ 27.05
US$ 29.04
US$ 27.60
